2019
DOI: 10.1007/s00018-019-03162-w
|View full text |Cite
|
Sign up to set email alerts
|

Deregulated miRNAs in osteoporosis: effects in bone metastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
42
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(42 citation statements)
references
References 124 publications
0
42
0
Order By: Relevance
“…miR‐29b is a miRNA that regulates both osteoblastogenesis and osteoclastogenesis . Furthermore, serum miR‐29b is down‐regulated in PCa patients and this increases the formation of osteolytic lesions, influencing osteoblast and osteoclast differentiation and activities . These results suggested that overexpression in serum of circFOXO3 could influence osteolytic lesions formation through these processes in PCa.…”
Section: Discussionmentioning
confidence: 95%
“…miR‐29b is a miRNA that regulates both osteoblastogenesis and osteoclastogenesis . Furthermore, serum miR‐29b is down‐regulated in PCa patients and this increases the formation of osteolytic lesions, influencing osteoblast and osteoclast differentiation and activities . These results suggested that overexpression in serum of circFOXO3 could influence osteolytic lesions formation through these processes in PCa.…”
Section: Discussionmentioning
confidence: 95%
“…In the last few years, the increasing amount of information acquired about the biology of cancer cells and the molecular mechanisms that govern the onset and progression of the tumor has allowed the development of new drugs [40,41]. However, the high mortality rate in subjects with CRC and the increased risk of metastases, including distant bone metastases with subsequent complications such as pain and pathological fractures due to bone destruction [42,43], indicate the need of more effective and targeted therapies, especially for the treatment of metastatic colon cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Effects of miR-based therapy have been investigated in the context of the BM microenvironment [134] and bone disease (BD) [135]. Specifically, replacement of miR-29b in osteoclasts prevented bone resorption by reducing expression of c-FOS and MMP2 [136].…”
Section: Sncrnasmentioning
confidence: 99%